Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
Journal: Clinical breast cancer
Published: June 01, 2021
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: September 05, 2019
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Journal: Investigative radiology
Published: November 01, 2014
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
Journal: Investigational new drugs
Published: July 22, 2014
Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?
Journal: Ecancermedicalscience
Published: March 03, 2014
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Journal: Magnetic resonance in medicine
Published: October 23, 2012
Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
Journal: Journal of cardiac failure
Published: August 29, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026